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ABSTRACT: In this present study, antimicrobial activities of aqueous and methanolic extracts of 
cyanobacteria against some of fungi and pathogenic bacteria were investigated. Cyanobacteria strains 
Fischerella ambigua ISC67 and Schizothrix vaginata ISC108 were cultured in BG-11 medium. Extraction 
was performed by adding the solvent to cyanobacterial biomass and then filtering and drying of the mixture. 
The antimicrobial activity was evaluated by disc diffusion method and broth microdilution method was 
applied to determine the minimum inhibitory concentration. The results show that the aqueous and methanolic 
extracts of F. ambigua has a significant antimicrobial effect while, the tested extracts of S. vaginata was no 
significant antibacterial and antifungal activity. Highest antibacterial activity from aqueous extract of F. 
ambigua was against S. aureus (PTCC 1112) which the average zone diameter around it was 33.33 mm. The 
antibacterial effect of aqueous extracts against Gram-positive bacteria was more than Gram-negative bacteria 
significantly. Antifungal activity showed that methanolic extract of F. ambigua have significant antifungal 
activity. Minimum inhibitory concentration of active extract against most tested bacterial and fungal was 125 
mg/ml. The present study has proved that the aqueous and methanolic extracts of F. ambigua possessed strong 
antibacterial and antifungal properties against the pathogenic microorganism. Therefore, cyanobacteria can be 
a rich source for natural products with antimicrobial activity. 
Keywords: Cyanobacteria; Antimicrobial activity; Disc diffusion; Broth microdilution; Staphylococcus 
aureus. 
1. INTRODUCTION 
 Natural products play a great role in the discovery and development of new drug. These products have 
been isolated from a wide variety of natural sources and tested for various biological activities [1]. The 
screening of extracts or isolated compounds from different natural sources is a common way to discover 
biological active metabolites. In such research activities microalgae like cyanobacteria were found to be a rich 
source for various products of commercial, pharmaceutical or toxicological interest: primary metabolites, such 
as proteins, fatty acids, vitamins or pigments, various secondary metabolites with different bioactivities 
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(antifungal, antiviral, antibiotic and other) or cyanotoxins like the hepatotoxic microcystins and nodularins or 
the neurotoxic anatoxins and saxitoxins were isolated from cyanobacteria [2]. Cyanobacteria are the Gram-
negative photosynthetic bacteria, morphologically very diverse, and inhabiting a multiplicity of environments 
worldwide [3]. Also, cyanobacteria adapt to our changing environmental conditions, and thrive in water 
sources impacted by development and climate change [4]. These microorganisms are known to produce 
metabolites with diverse biological activities such as antibacterial, antifungal, antiviral, anticancer, algaecide 
activities [5-7]. Screening of cyanobacteria for antimicrobial and other pharmacologically active compounds, 
has received ever-increasing interest as a potential source for new drugs [8]. Cyanobacteria from local habitats 
seem to be a source of potential new active substances that could contribute to reduction of the number of 
bacteria, fungi, viruses and other microorganisms [9]. 
 The increasing clinical incidence of antibiotic-resistant bacteria is a major global health care issue [10]. 
Resistance to antibiotics and drugs in pathogenic bacteria has progressively become a clinical-annoyance, 
since patients admitted to hospitals carry drug resistant bacteria, which have nosocomial spreads [11]. This 
has led to a development of natural antimicrobials compounds [12]. Cyanobacteria secondary metabolites can 
be a good candidate for inhibition of many pathogenic bacteria. Recently, researchers at several institutions 
have started to screen extracts of cyanobacteria for various  biological activities and about 4000 species of 
cyanobacteria have been screened for novel  biological active compounds. This indicates that cyanobacteria 
are a rich source of potentially  useful natural products [13]. Cyanobacteria of Iran have not yet been many 
studied for antimicrobial activity and little work has been done to screen cyanobacteria to their production of 
bioactive compounds. The general objective of this study was evaluation of antibacterial and antifungal 
activity of aqueous and methanolic extract of cyanobacteria against some of fungi and pathogenic bacteria.  
2. MATERIAL AND METHODS 
2.1. Cultivation of cyanobacteria  
 In this experimental study, the cyanobacteria strains Fischerella ambigua ISC67 and Schizothrix 
vaginata ISC108 were obtained from the algal culture collection of research institute of applied science, 
ACECR, Tehran, Iran. These microorganisms were cultured in a 500 ml flask containing 150 ml of BG-11 
medium without shaking, for 30 days. The incubation temperature was 28°C ± 2 and illumination at 3000 lux 
with a white continuous light [5].  
2.2. Extraction procedure 
 Extraction was carried out using Val method [14]. Briefly, at the stationary phase of growth (30 days), 
cultures were harvested by centrifugation at 5000 rpm for 15 min. The supernatant was collected and the 
culture pellet was extracted with 30 ml of methanol, with shaking 150 rpm for 20 min. The culture 
supernatants and solvent extracts were dried under reduced pressure at 60°C and were stored at -20°C for 
further studies. The aqueous and methanolic extracts obtained from cyanobacteria were analyzed for the 
presence of antimicrobial activity.  
2.3. Preparation of bacterial and fungal strains 
 Five Gram-positive phatogenic bacteria including; Staphylococcus aureus (PTCC 1112), 
Staphylococcus epidermidis (PTCC 1114), Bacillus cereus (PTCC 1247), Enterococcus faecalis (PTCC 1237), 
Streptococcus pyogenes (PTCC 1447) and five Gram-negative phatogenic bacteria including; Escherichia coli 
(PTCC  13 38 ), Pseudomonas aeruginosa (PTCC 1430), Proteus vulgaris (PTCC 1312), Salmonella paratyphi 
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B (PTCC 1231) and Klebsiella pneumonia (PTCC 1053) obtained from the Persian Type Culture Collection, 
Tehran, Iran (PTCC). The plant fungal pathogen species including; Fusarium oxysporum, Rhynchosporium 
secalis, Fusarium solani and Botrytis cinerea obtained from Laboratory of Plant Pathology, University of 
Ilam, Iran. Bacterial strains were inoculated on nutrient broth and incubated at 37°C for 24 h. The fungal 
strains were inoculated on potato dextrose broth and incubated at 30°C for 5 days. To antimicrobial test all 
strains of bacteria and fungal were adjusted to 0.5 Mc-Farland standard by optical density (OD) method at 620 
nm (1 x 108 cfu/ml for bacteria and 1 x 106 cfu/ml for fungal) [15]. 
2.4. Antibacterial and antifungal bioassay 
 The antibacterial activities of cyanobacteria extracts was assayed by agar disc diffusion method [16]. 
Briefly, different concentrations of each dry extract, (125, 250, 500 and 1000 mg/ml), prepared in dimethyl 
sulfoxide (DMSO). Bacterial and fungal suspensions that were adjusted to 0.5 Mc-Farland standard 
individually were swabbed on Muller-Hinton agar and potato dextrose agar (PDA) plates at three directions 
according to CLSI [17]. Then, filter paper discs (6.0 mm) were saturated with each extracts, dried under 
laminar air flow and placed on the Muller-Hinton agar plate for bacteria and potato dextrose agar (PDA) for 
fungi. Plates were incubated at 37°C for a period of 18 to 24 h for bacteria and at 25°C for a period of 24 to 
48 h for fungi. Discs treated with 50 μl DMSO was used as negative controls and commonly used antibiotics 
was used as positive controls. The aqueous and methanolic extracts containing antibacterial components 
produced distinct, clear, circular zones of inhibition around the discs and the diameters of clear zones were 
determined and used as an indication of antibacterial activity.  
2.5. Determination of Minimum Inhibitory Concentration (MIC) 
 Minimum inhibitory concentration of active crude extracts was determined by broth microdilution 
method [18]. The test was performed using polystyrene 96well plates. Two fold serial dilutions of all active 
extracts were made in Cation-Adjusted Muller-Hinton Broth ranging from 1000 to 125 mg/ml. Each inoculum 
was prepared with 50 μl Muller-Hinton Broth for bacteria and potato dextrose broth for fungi, then 50 μl of 
the diluted active extracts and 50 μl of the prepared bacterial and fungal suspension was added for the assay. 
After 24 h of incubation at 37°C for bacteria and 48 h of incubation at 25°C for fungi. MIC was defined as the 
lowest concentration of the extracts at which the microorganisms showed no visible growth.  
2.6. Statistical analysis  
 All the experiments were done in triplicate. The SPSS software version 20 was used for data analysis. 
The results are expressed as the mean ±SD of three experiments. The experimental data obtained were 
analyzed for multiple comparisons using one-way ANOVA and when the results were significant, the Duncan 
test was also used.  
3. RESULTS  
 In this study, the antibacterial and antifungal activities of two strains of cyanobacteria, Fischerella 
ambigua ISC67 and Schizothrix vaginata ISC108, were determined by disc diffusion method. The result show 
that from the tested extracts, the aqueous and methanolic extracts of F. ambigua have a significant 
antimicrobial effect while, the tested extracts of S. vaginata has no significant antibacterial and antifungal 
activity (p-value ≤ 0.01). The results of aqueous and methanolic extracts of F. ambigua that demonstrated 
antibacterial activity are shown in Table 1. As shown in Table 1, methanolic extract of F. ambigua has no 
considerable effect against tested bacteria, however, this extract had significant effect against Bacillus  cereus 
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 (P TCC  12 47 ) , Proteus  vulgaris  (P TCC  13 12 ) and Klebsiella  pneumonia (p-value ≤ 0.01). The results also 
clearly showed that aqueous extract of this cyanobacterium strains had significant antibacterial activity 
against most pathogenic bacteria, so that maximum antibacterial activity was against Staphylococcus aureus 
(PTCC 1112) which the average zone diameter around it was 33.33 mm (Figure 1). The results indicated that 
both extract had antibacterial activity against gram positive and gram negative bacteria. The antibacterial 
effect of aqueous extracts against gram-positive bacteria was more than gram-negative bacteria significantly 
(p-value ≤ 0.01), however, compression of antibacterial activity of methanolic extract against Gram-positive 
bacteria and Gram-negative bacteria was not significantly according to statistical analysis (p-value ≤ 0.02). 
Among the tested bacteria only two strains of the bacteria, Bacillus cereus (PTCC 1247) and Proteus vulgaris 
(PTCC 1312), were inhibited by both aqueous and methanolic extracts of F. ambigua.  Also the result show 
that extracts obtained from F. ambigua has not considerable antibacterial activity against Streptococcus 
pyogenes (PTCC 1447), Escherichia coli (PTCC 1338), and Pseudomonas aeruginosa (PTCC 1430). Among 
the commonly used antibiotics, Penicillin was the minimum effective antibiotic against tested bacteria. 
Results indicated that antibacterial activity of aqueous and methanolic extracts of F. ambigua against some of 
bacteria was more than commonly used antibiotics. For example, the antibacterial activity of aqueous extract 
of F. ambigua against S. aureus (PTCC 1112) and S. epidermidis (PTCC 1114) and also antibacterial activity 
of methanolic extract of F. ambigua against P. vulgaris (PTCC 1312) were more than commonly used 
antibiotics against these bacteria.  
 The results indicated that the MICs value of aqueous and methanolic extracts against most sensitive 
pathogenic bacteria was 125 mg/ml, while it was 250 mg/ml against P. vulgaris (PTCC 1312) (Table 1). 
Evaluation of antifungal activity showed that methanolic extract of F. ambigua has significant antifungal 
activity against most pathogenic fungal (p-value ≤ 0.01), so that maximum antifungal activity was against 
Rhynchosporium  secalis which the average zone diameter around it was 32.33 mm. The results also indicated 
that aqueous extract of F. ambigua has no considerable effect against tested fungal, however, this extract had 
significant effect against Fusarium oxysporum (Table 2). Minimum inhibitory concentration of aqueous and 
methanolic extracts of F. ambigua against pathogenic fungal has been shown that the MICs of active extract 
against tested fungal was 125 mg/ml, whereas it was 250 mg/ml against Fusarium  solani affected by extract 
(Table 2).   
 
 
Figure 1. Inhibitory effects of different concentrations of aqueous extracts from F. ambigua against Staphylococcus 
aureus (PTCC 1112) and Enterococcus faecalis (PTCC1237). 
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Table 1. The average diameter of inhibition zone and standard deviation of antibiotics and aqueous and methanol extract of Fischerella ambigua against pathogen bacteria (mm).  
* R; Resistant 
**MIC; Minimum inhibitory concentration value expressed in mg/ml 
***ND; Not determinated 
 
Klebsiella 
pneumoniae 
Salmonella 
paratyphi 
Proteus 
vulgaris 
(PTCC 1312) 
Pseudomonas 
aeruginosa 
(PTCC 1430) 
Escherichia 
coli 
(PTCC 1338) 
Streptococcus 
pyogenes 
(PTCC 1447) 
Bacillus 
cereus 
(PTCC 1247) 
Enterococcus 
faecalis 
(PTCC 1237) 
Staphylococcus 
epidermidis 
(PTCC 1114) 
Staphylococcus 
aureus  
(PTCC 1112) 
 
 
22±0 21.33±0.57 20.33±0.57 19.33±0.57 13±1 23.33±1.52 21.67±1.52 25.33±0.57 10.67±0.57 28.67±1.15 Gentamycin 
15.68±0.57 15±0 10±0 21±1.73 14.67±1.15 12±0 18.33±0.57 20.67±0.57 10.33±0.57 23.33±0.57 Streptomycin 
30.33±0.57 8.33±0.57 16.33±0.57 19.33±0.57 23.33±0.57 15.67±0.57 23.67±2.3 23.67±0.57 31.33±0.57 30.33±0.57 Chloramphenicol 
23.67±0.57 25.33±1.15 14.33±0.57 12.33±0.57 R 16.33±1.52 19.33±0.57 16.67±1.15 R* 15.33±0.57 Nalidixic acid 
R R R R R R R 16±1 R 27.33±0.57 Penicillin 
23.33±0.57 6±0 27.33±0.57 6.33±0.57 6±0 6±0 20.67±1.15 6±0 6±0 6±0 1000 
Methanolic 
extract of  
Fischerella sp.  
(mg/ml) 
21±1 6±0 23.67±0.57 6±0 6±0 6±0 19±0 6±0 6±0 6±0 500 
20±0 6±0 20.67±0.57 6±0 6±0 6±0 18±1 6±0 6±0 6±0 250 
17.33±0.57 6±0 19.33±0.57 6±0 6±0 6±0 14.33±0.57 6±0 6±0 6±0 125 
125 ND 125 ND ND ND 125 ND ND ND MIC** 
6±0 21±1 19.33±0.57 6.33±0.57 6±0 6±0 20.33±0.57 24±1 32.33±0.57 33.33±0.57 1000 
Aqueous 
extracts of  
Fischerella sp. 
 (mg/ml) 
6±0 16.33±0.57 16.67±0.57 6±0 6±0 6±0 19.33±0.57 21.33±0.57 27.33±0.57 30±0 500 
6±0 12.67±0.57 13.67±1.15 6±0 6±0 6±0 17.33±0.57 19.67±0.57 25±1 28.67±1.15 250 
6±0 10.33±0.57 8±0 6±0 6±0 6±0 12.33±0.57 13.67±0.57 17.33±0.57 22±0 125 
ND 125 250 ND ND ND*** 125 125 125 125 MIC 
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Table 2. The average diameter of inhibition zone and standard deviation of antibiotic and aqueous and methanol extract of 
Fischerella ambigua against pathogenic fungi (mm). 
*MIC; Minimum inhibitory concentration value expressed in mg/ml 
**ND; Not determinated 
 
4. DISCUSSION 
 In this present study, cyanobacterium F. ambigua shown antibacterial and antifungal activity against 
pathogenic microorganism, while S. vaginata was no significant antimicrobial activity. Cyanobacteria are 
known to have wide variety of secondary metabolites with antimicrobial properties. Antibacterial and 
antifungal  effects of curd extracts from many cyanobacteria strains, such as Fischerella sp., Oscillatoria 
angustissima, Spirulina platensis, Synechococcus and other species have been reported [19, 20]. In the resent 
years, several reports have been published of antibacterial compounds isolated from cyanobacteria, such 
examples as ambiguine, isonitriles, aoscomin, comnostins A-E, norharmane, lyngbyazothrins, and 
carbamidocyclophanes [2]. Terpenoids and phenolic compounds were thought to inhibit microorganisms by 
membrane disruption [21]. Also, flavonoid activity is probably due to their ability to complex with 
extracellular and  soluble proteins and with bacterial cell wall which inhibition of the porin on the cell 
membrane and by alteration of the membrane permeability leads to the cell destruction [22]. Thus, it has been 
suggested that the antimicrobial activity of these extracts could be attributed to the high contents of this 
natural compounds such as terpenoids, phenolics, flanonoeids, ambiguine and etc. 
 Susceptibility of the tested  microorganisms to the cyanobacteria extracts was different. The 
susceptibility varied according  to strains and species which were also in agreement with our results. The 
 extract with low activity against a particular organism gave high MIC, while the highly reactive  extract gave 
low MIC value. The MIC technique is used to evaluate the efficiency of antimicrobial  agents [18]. The 
aqueous extract of F. ambigua have significant antibacterial activity against most pathogenic bacteria, These 
results was corresponded with Madhumathi et al. [23] and Chauhan et al. [24], which found that some 
cyanobacteria had high antibacterial activity against Staphylococcus aureus, Staphylococcus epidermis, 
Salmonella paratyphi, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, Streptococcus 
pyogenes, Streptococcus enteritidis, Bacillus cereus and Proteus vulgaris. According to the result, aqueous 
Botrytis 
cinerea 
Fusarium 
solani 
Rhynchosporium 
secalis 
Fusarium 
oxysporum 
 
 
28±1 17±0 35.67±0.57 22.67±1.15 Nystatin 
20±1 14.33±0.57 32.33±0.57 15.33±0.57 1000 
 
Methanolic extract of  
Fischerella sp.  
( mg/ml) 
18.33±0.57 12.67±0.57 25.67±0.57 14.67±1.15 500 
15.67±0.57 11.67±1.15 22.67±0.57 13.33±0.57 250 
14.33±0.57 9.33±0.57 18.67±0.57 11.33±0.57 125 
125 125 125 125 MIC* 
6±0 6±0 6±0 10.67±0.57 1000 
 
Aqueous extracts of  
Fischerella sp.  
(mg/ml) 
6±0 6±0 6±0 9.67±0.57 500 
6±0 6±0 6±0 8.33±0.57 250 
6±0 6±0 6±0 6±0 125 
ND ND ND** 250 MIC 
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extracts of F. ambigua was most effective against Gram-positive bacteria as compared to Gram-negative 
strains, These results was corresponded with Safari et al. [19] and Madhumathi et al. [23] that showed the 
effective of extracts from cyanobacteria against gram positive bacteria was more than gram negative bacteria. 
A possible explanation for these observations may be attributed to the significant differences in the outer 
layers of gram- negative and positive bacteria. Gram negative bacteria possess an outer membrane and a 
unique periplasmic space not found in Gram positive bacteria. The resistance of Gram negative bacteria 
towards antibacterial substances is related to the hydrophilic surface of their outer membrane which is rich in 
lipopolysaccharide molecules, presenting a barrier for the penetration of numerous antibiotic molecules. The 
membrane is also associated with the enzymes in the periplasmic space, which are capable of breaking down 
the molecules introduced from outside [25]. Antifungal activity of F. ambigua indicated that methanol was 
best solvent for extracting antifungal compound from this microorganism, so that methanolic extract was 
effective against even four tested pathogenic fungal. This result has corresponded with previously study that 
indicated methanol is best solvent for extracting antifungal compound from cyanobacteria [26], but has not 
corresponded with Ghasemi et al. [27] investigations. Smithka et al. [28] reported that ambiguine produced by 
cyanobacteria possess antifungal activity and probably antifungal activity of F. ambigua methanolic extract in 
this study due to their ability to production of ambiguine. A variety of solvents (water, methanol, ethanol, 
acetone, petroleum ether, and hexane) used for extracting the antibacterial agents and methanol was best than 
other solvents [29]. In contrast to the Challouf et al. [29], in this study, methanol were not the best solvents for 
extracting the antibacterial agents from Fischerella sp. and culture supernatants (aqueous extract) gave the 
highest inhibition zone than other solvents that these results go in harmony with Ghasemi et al. [27]. 
However, in present study it was found that methanol was best solvent for extracting of antifungal compound.  
5. CONCLUSION 
 The present study has proved that aqueous and methanolic extracts of F. ambigua possessed strong 
antibacterial and antifungal properties against the pathogenic microorganism. Antibacterial activity of aqueous 
extract of F. ambigua was more than methanolic extract and it can be concluded that methanol were not the 
best solvents for extracting the antibacterial agents from cyanobacteria. According to our knowledge, this is 
the first study about antimicrobial activity of Fischerella ambigua ISC67 and Schizothrix vaginata ISC108 
and antifungal activity of these cyanobacteria. According to the results of this study, cyanobacteria extract can 
be a rich source for natural products with antimicrobial activity to development of new drug. Improvement 
knowledge of the composition, analysis, and the properties of these cyanobacteria extract with respect to 
antimicrobial compounds would encourage emphasis for search of drug molecules. Also Further studies are 
needed to isolate the active principles and bioactive compounds from the extract and to elucidate the exact 
mechanism of action of the free radical scavenging effect and antibacterial activity. 
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